XRP ETF Timeline Remains Unclear as 21Shares Filing Decision Delayed
An anticipated decision on a 21Shares XRP ETF product did not materialize on the date some market observers expected, adding uncertainty to the near-term timeline for a U.S. spot XRP ETF. The delay does not constitute a denial, and regulatory review is understood to be ongoing. No official SEC statement has been issued.
A regulatory decision on a 21Shares XRP exchange-traded fund was expected by some market participants but did not arrive on the anticipated date. The absence of a ruling prolongs the period of uncertainty around when, or whether, a U.S. spot XRP ETF might receive approval.
Several XRP ETF applications from different issuers are currently under SEC review. The 21Shares filing is one of a broader set of proposals that regulators are working through following the wave of Bitcoin ETF approvals in early 2024 and subsequent Ethereum ETF approvals.
A missed expected date does not signal a denial. SEC review timelines can extend through multiple comment periods and amendment cycles before a final decision is reached. Observers are watching for any formal acknowledgment or amendment filings that might indicate the review is progressing.
The XRP ETF category remains one of the higher-stakes regulatory outcomes for the asset, given the potential for institutional inflows that a listed product could facilitate.
Key facts
- •A 21Shares XRP ETF decision was anticipated but did not arrive on the expected date
- •No SEC denial has been issued; review is understood to be ongoing
- •Multiple XRP ETF applications are currently before the SEC
- •No official SEC communication has been publicly confirmed